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The Fate ofReleased Histamine:
Reception, Response and Termination
P.K. Rangachari
Department ofMedicine, McMaster University, Hamilton, Ontario, Canada
Histamine released from ECL cells elicits responses from a variety ofcellular
targets in the vicinity. Three sets of receptors are involved (H1, H2 and H ).
Receptor occupation is promptly transduced into cellular responses. TWe
responses, inturn, are terminatedbydiversemechanisms: enzymatic inactivation,
cellular uptake and desensitization at the receptor level. Under specific patho-
logical conditions, histamine effects could be exaggerated by the presence of
derivatives that may be ofmarginal relevance under physiological conditions.
INTRODUCTION
The enterochromaffm-like cell (ECLcell) plays acrucial role in theregulation ofgastric
acid secretion [1], using as its preferred messenger, histamine. Molecules that function as
messengers in a biological system must be produced and received by target cells that
respond in specific ways to their presence. The actions of the messenger must be termi-
nated to permit the target cell torespond to the next message [2]. Histamine is no exception.
This presentation will highlight some ofthe above elements. Since other presentations in
this session deal with the production of histamine, I will focus largely on the conse-
quences of histamine release. Thus, I will discuss the reception and responses of target
cells in the stomach and the mechanisms by which the message is terminated. In the inter-
ests of space, I have chosen to cite recent reviews more often than the original articles.
In the ECL cell, histamine ([2-(4-imidazolyl)ethylamine]) is produced by the decar-
boxylation of histidine by histidine decarboxylase (see Figure 1). The regulation of the
enzyme in the ECLcell has been a subject ofmuch study [1, 3] and will be the subject of
otherpresentations in this symposium. The histamine that is synthesized is packagedinto
granules and released in response to diverse stimuli. Ofthese, gastrin acting on a gastrin/
CCK-B receptor plays the major role. Other agonists that increase histamine secretion
include acetylcholine, prostaglandins, isoproterenol andVIP, and the inflammatory cytokine,
interleukin 1. Inhibition ofsecretion involves somatostatin, CGRPand histamine itself [1].
Once released, histamine functions as a messenger eliciting responses from a variety
of target cells in the neighborhood of the ECL cell (see Figure 2). These cells are abun-
dant in the basal third ofthe mucosa which is rich in chiefcells rather than parietal cells.
The histamine released must reach the major target cell, the parietal cell, by diffusion or
capillary transport [4]. Other targets include surface epithelial cells, chief cells, smooth
muscle cells, immunocompetent cells, vascular and neural elements and the ECL cell
itself which also responds to the released histamine.
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Figure 1. Shows the structure of Histamine and the nomenclature suggested by Black and
Ganellin [39]. There are three nitrogens. Of these, the side-chain N is termed alpha to distinguish
it from the two ring N which are termed pros (iX) for the one closer to and tele (X) for the one further
from the side-chain.
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Figure 2. Shows the potential targets for histamine released from the ECL cell. On the gastric
mucosa, potential cells include surface epithelial (S), parietal (P) and chief (C) cells.
RECEPTION
In any communication system, it is essential to have a system that receives and
responds to the message. In biological systems, the receiving elements are broadly catego-
rized as extracellular or intracellular receptors. With respect to histamine, the extracellular
receptors have been well studied. Although reports exist for the existence of intracellular
receptors, these must be viewed with some skepticism at the cufrent moment. The recep-
tors for histamine are expressed on a variety oftarget cells in proximity to the ECL cell.
NIPP
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Table 1. Histamine receptor sub-types.
Features Hi H2 H3
Selective agonists: * 2-pyridylethylamine * Dimaprit * R(-)amethyl-
* 2-thiazolylethylamine * Impromidine histamine
* 2-(3-trifluoromethyl) *Amthamine * Imetit
phenyl histamine * Immepip
Selective antagonists: * Mepyramine * Ranitidine * Thioperamide
* Chlorpheniramine * Tiotidine * Clobenpropit
* Triprolidine * lodophenpropit
Coupled to: * Coupled to * Adenylate cyclase * Negative coupling
phosphoinositol activation phospholipase
metabolism activation
Cell types: * Smooth muscle cells * Parietal cells * ECL cells
(muscularis mucosae) * Smooth muscle cells
arterioles (muscularis mucosae)
* Surface cells arterioles
* ECL cells * Surface cells
The standard pharmacological approach to the classification of receptors involving
the careful use of selective agonists and antagonists [5] has led to the current classifica-
tion of histamine receptors into three general categories: H1, H2 and H3 [6] . The salient
characteristics ofeach ofthe three receptor subtypes are summarized in Table 1.
The H1 receptor responds not only to histamine, its natural agonist but also preferen-
tially to several synthetic analogues (2 pyridylethylamine, 2 thiazolyl ethylamine). The
responses to stimulation are markedly inhibited by alarge numberofsynthetic compounds
of varying selectivity. The reference compounds in general use are mepyramine (pyril-
amine) and chlorpheniramine. The latter compound is particularly useful for experimental
purposes as the d(+) form is approximately two orders ofmagnitude more potent than the
1(-) form in some systems. The original H1 antagonists readily penetrated the blood-brain
barrier and produced sedation. In an attempt to mitigate against these, a new series of
compounds have been produced that are potent and effective H1 antagonists [6].
The H2 receptor responds not only to histamine but to selective agonists, such as
dimaprit and impromidine. Dimaprit is a highly selective H2 agonist that has virtually no
agonist effects on H1 receptors but is a moderately active H3 antagonist. Impromidine is
more potent than histamine as an H2 agonist and is an antagonist at H3 and H1 receptors.
Forexperimental studies the preferred H2 antagonists are cimetidine, ranitidine and tiotidine.
The agonists that act preferentially on the H3 receptors include R(-)-a-methylhistamine
and a more recently described compound, imetit [6, 7]. The antagonists for this receptor
include the H2 agonist, impromidine, as well as thioperamide and more recently cloben-
propitderived from the highly active agonist imetit [6]. The possibility that subtypes ofthe
H3 receptor (labeled H3A andH3B) may be present needs exploration andconfirmation [7].
The availability of these pharmacological tools permits exploration of the effects of
histamine on a variety ofcellular systems. The classical pharmacological approaches have
been immensely strengthened by molecular biological approaches which have led to the
cloning of the genes for the H1 and H2 receptors and the deduction of the amino acid
sequences of the receptor proteins.
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The genes for the H1 receptor have been cloned from several species (bovine, rat,
guinea-pig, andhuman). The genes codeforproteins thatarebetween486to491 aminoacids
and show considerable homology. The proteins bear the hall mark ofthe classical G-protein
coupled receptors (7 transmembrane domains, with phosphorylation sites for protein
kinase A and protein kinase C as well as N-terminal glycosylation sites). The deduced
structures show a very large intracellular loop and a very short C-terminal tail. Although
the different receptors show over 90 percent homology in the intracellular domains, there
is greater variability in the long intracellular loop or in the N-terminal tails.
The genes that encode for the H2 receptors have been cloned from several species
(dog, human, rat). They too encode for proteins that exhibit the structural features of G-
protein coupled receptors. In contrast to the H1 receptor protein, the H2 receptor proteins
have short third intracellular loops and relatively long C-terminal tails. It is believed that
these features are associated with positive coupling to the adenylyl cyclase system.
In contrast to the H1 and H2 receptors, the low abundance of H3 receptors has made
characterization difficult. Nevertheless, it has been recently reported that a protein has
been purified from the human gastric tumoral cell line HGT-I that bound labeled N-
methylhistamine which was inhibited by thioperamide and (R)-a-methylhistamine, sug-
gesting that this could be linked to H3 receptors [8]. Molecularbiological approaches may
ultimately lead to the cloning ofthe gene for the third histamine receptor as well.
As mentioned above, there are many cellular targets for the histamine that is released
from the ECLcell. The expression ofspecific receptors on these target cells vary. The classic
example of an H2 receptor is that observed on the parietal cell in a variety ofspecies (4).
The muscularis mucosal smooth muscle at least in dogs expresses bothHi and H2 receptors
[9, 10]. Non-parietal cells from the stomach of diverse species appear to have either H2
receptors alone or both H1 and H2 receptors The former situation is seen in rats [11] and
guinea-pigs [12] and the latter in rabbits [13]. On the arterioles in the gastric vasculature
both Hi and H2 receptors have been described [14]. The responses of the chief cell are
species dependent and highly variable, at least in vitro. The effects are antagonized by
cimetidine, suggesting an H2 receptor [15].
RESPONSE
Reception ofa message mustbe followedby appropriate action otherwise the message
is wasted. Cells have evolved exquisite mechanisms to translate information received into
meaningful action. A limited repertoire of intracellular signals is used in various combi-
nations to link occupation ofexternal receptors to physiological responses. In the case of
G-protein coupled receptors, a class to which bothHi and H2 receptors belong, the occu-
pation of the receptors is linked to the activation of a G-protein which in turn leads to the
activation of various effectors. Transduction mechanisms involving histamine involve
changes in either cyclic nucleotides, principally cAMP or intracellular Ca. cAMP is gen-
erated from ATP by the activation of adenylyl cyclase, which is controlled by two GTP-
binding proteins, that either stimulate or inhibit the enzyme. Alterations in intracellular
calcium could stem from either release of intracellular Ca from internal stores or by an
increase in the influx ofextracellular Ca. In the former case, a key role is played by inos-
itol phosphates that are mobilized from membrane phospholipids by the activation of
phospholipase C.
Current opinion links H1 receptors to the phospholipase-C dependent hydrolysis of
phosphoinositides with consequent changes in intracellular Ca and H2 receptors predom-
inantly with the activation of adenylyl cyclase and the generation of intracellular cAMP
[6]. But as with all generalisations exceptions exist. Alterations in Ca, produced as aresultof
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an H1 response could in turn activate a number of other second messengers principally
cAMP, cGMP, nitric oxide or arachidonic acid metabolites [6]. Conversely, H2 effects that
are not related to activation of adenylyl cyclase have been described in several systems
including the parietal cell, transformed hepatoma-derived HEPAcells and HL-60 promye-
locytic leukaemic cells. Recent studies with transfected HEPA cells and CHO cells are
particularly interesting as they demonstrate the promises and pitfalls ofmolecularbiolog-
ical approaches to these problems. Ithadbeen shown thatthe transfection ofmouse Lcells
with a plasmid containing an insert of the coding region of the H2 receptor from canine
parietal cells led to a histamine-stimulated increase in cAMP that was inhibited by cime-
tidine. This was an elegant demonstration of the linkage between H2 receptor activation
and adenylyl cyclase stimulation [16]. Later studies by the same group complicated the
picture. They showed that in HEPAcells transfected with the canine H2 receptorgene, his-
tamine increased not only cAMP levels but also inositol triphosphates and intracellular
Ca. These effects were inhibited by cimetidine but not by diphenhydramine or thiop-
eramide testifying to the selectivity ofthe effects seen. That forskolin was unable to alter
intracellular Ca suggested that it was the histamine response that was coupled to the two
separate pathways [17]. On the contrary, in another cell system, CHO cells, expression of
human H2 receptors, did not lead to any alterations in intracellular Ca or inositol phos-
phates [6]. Expression ofcloned rat H2 receptors in the same cell system led to the demon-
stration of another cAMP-independent effect ofhistamine stimulation - the marked inhi-
bition of arachidonic acid release induced by other stimulants [18]. The demonstration of
these novel effects may be related to the level of expression of the specific receptors
which may alter the balance between receptive and transducing elements. It is thus imper-
ative that the data obtained from such studies be placed in context ofwhat is known from
physiological experiments.
The transduction mechanism linking occupation of H3 receptors to the observed
physiological responses have not been clearly defined. Given that the effects are predom-
inantly inhibitory, several possibilities exist ranging from inhibition of adenylyl cyclase
activity to inhibition ofphopholipase C activation or Ca release. A recent report suggests
that in the HGT-1 gastric tumor cell line, a negative coupling exists between the occupation
of H3 receptors and phospholipase C activation [8]. Other reports link the receptor to a
reduction in entry ofextracellular Ca. Ifthe studies on the other two receptors are any indi-
cation, it is likely that H3 receptors would be linked to one predominant mode ofoperation
with exceptions being noted under particular set ofcircumstances.
The transduction of the message received is not an end itself. It must be followed by
appropriate action. The consequences of the transduction are obviously related to the
functional capacity ofthe target cell. Thus in response to the same agonist, smooth muscle
cells either contract or relax whereas the parietal cell produces HCl. The sequence of
events linking occupation of H2 receptors on the parietal cell to the secretion of acid are
complex. Acurrent paradigm links alterations in levels ofcAMP to the activation ofprotein
kinases which in turn phosphorylate a variety of intracellular proteins. Since the process
of acid secretion by the parietal cell is a complex one [19] involving concerted morpho-
logical and biochemical transformations, the number ofcandidate proteins is large ranging
in location from cytosolic, microsomal and membrane proteins. More recent studies suggest
that H2 receptor activation led to an increased expression of mRNA for the x subunit of
the gastric H/K-ATPase itself [20, 21].
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Figure 3. Shows schematically the mechanisms responsible for the inactivation of histamine.
Of the two metabolic pathways, methylation is predominant in the stomach.
TERMINATION
The efficient operation of any information system demands the presence of mecha-
nisms that terminate responses to a particular message to ensure that the system is ready to
respond to the subsequent one. To forget is as important as it is to remember. It is no surprise
that biological systems have evolved interesting mechanisms for that purpose. The mes-
senger molecule may be inactivated enzymatically or be internalized. Alternatively the
responding system may get desensitized. These possibilities have been documented for
histamine (Figure 3).
Two major enzymatic systems exist to inactivate histamine [22]. Diamine oxidase
was the earliest system to be described. It converts histamine initially to imidazole
acetaldehyde and subsequently to the corresponding acid which is then conjugated with
ribose-phosphate. The second system involves methylation ofthe imidazole nitrogen and
is carried out by histamine methyltransferase. The enzyme is widely distributed and is of
particular relevance in the stomach where it is the major inactivating mechanism [23, 24].
It catalyses the transfer of a methyl group from S-adenosyl-L-methionine to histamine
producing N-tele-methylhistamine which can be subsequently oxidized to the corre-
sponding acetic acid derivative. In the canine fundic mucosa, the enzyme was primarily
associated with parietal cells [25]. Inhibition ofthe enzyme leads to an enhanced response to
both histamine and pentagastrin [22] . In rabbit gastric glands, methylation occurs intra-
cellularly and a histamine uptake process that is dependent on external sodium. In the rabbit
gastric mucosa, the methylated histamine is released preferentially into the serosal solu-
tion [26]. A more complex process has been demonstrated in fibroblasts and pulmonary
endothelial cells where histamine is methylated by transferases and the methylatedproduct
converted by exogenous diamine oxidase from diverse sources such as activated neu-
trophils to N-tele-methylimidazole acetic acid which is transported into the cell by a
process that appears to be dependent on external Na and Cl [27]. The characteristics of
this process are at variance with the more conventional Na-dependent uptake processes
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that have been described, and the relevance to the case of histamine inactivation in the
stomach is unclear at present. However in the case ofinflammatory states, the presence of
neutrophils could provide an impetus for such a mechanism in the metabolic disposition
ofhistamine.
Inactivation of the messenger molecule is not the only means by which biological
messages are terminated. A more powerful control can be exercised at the level of the
receptive element itself. Such processes can be distinguished on the basis of the time
frame in which the events occur (rapid/slow), the generality ofthe process (receptor-spe-
cific or homologous)/general (heterologous) or on the basis of the particular mechanism
involved (loss of function/loss of receptors). The term desensitisation should be used to
define loss ofreceptor function by any mechanism and the much-abused term "down-reg-
ulation" should be confined to instances where there is a clear demonstration ofareduced
number ofreceptors eitherdue to reduced synthesis and/orenhanced degradation [28, 29].
As mentioned earlier, the histamine receptors belong to the generic class ofG-protein
coupled receptors. The attenuation of the responses noted in members of that family
involve three major mechanisms. Initially the receptors are uncoupled fromtheirrespective
G-proteins due to phosphorylation by serine/threonine kinases leading to a reduction in
responsiveness.The receptors are then internalized andfinally degraded to lead to areduction
in receptor numbers. These processes that have been analyzed in great detail with the proto-
typical P-adrenergic receptor have also been demonstrated with histamine receptors.
Short term desensitisation has been demonstrated with both H1 and H2 receptors in
several different cells [30-33]. Homologous H1 receptordesensitisation has been demonstrated
in intestinal smooth muscles from different regions [34]. In those preparations, the desensiti-
sation appeared to involve amodification ofthe HI receptor. In HeLacells histamine acting
onHi receptors produced a biphasic response [30], an initial rapid increase in intracellular
Ca due to release from intracellular stores and a later sustained increase due to influx of
extracellular Ca. Desensitisation seen with the first phase was independent of the protein
kinase C pathway whereas that observed with the second phase was dependent on the acti-
vation of the protein kinase C pathway. Rapid desensitisation has also been shown with
H2 receptor stimulation in several cell types including HGT-1 tumor cells and U937
monocytic cells [32, 33]. These effects were accompanied by an attenuation in the produc-
tion ofcAMP. In HEK293 cells, Smitet al. [35] noted arapid internalizationofthehistamine
receptor which was blocked by an endocytosis inhibitor phenylarsine. Since forskolin did
not induce internalization, the process occurred by a cAMP-independent pathway. More
prolonged exposures to histamine lead to a "down-regulation" of histamine receptors in
CHO cells as demonstrated with binding of labeled iodoaminoptentidine [36]. There
appeared to be two distinct pathways that were either dependent or independent ofcAMP.
VARIATIONS UNDER PATHOLOGICAL CONDITIONS
Much ofthe information discussed above has been obtained fromexperimental animals
or from normal human tissues. It is possible that the disposition ofhistamine under patho-
logical conditions could be significantly different. Two such conditions would be dis-
cussed below. It has been noted above that theprimary inactivating system in the stomach is
histaminemethyl transferase thatproduces N-tele-methyl histaminebymethylation ofthering
nitrogen. The product is essentially inactive. Although the presence of side-chain methy-
lated compounds in human urine had been documented as early as 1957, and Code et al.
[37] had shown that these N-methyl derivatives were potent secretagogues, theirrelevance
to human physiology has remained obscure. Amore recent report [38] suggests that in the
antral region of stomachs of patients infected with Helicobacter pylori, there was an
enhanced activity of N-histamine methyltransferase and the presence of N-methylhista-
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mine which is now known to be an potent agonist ofH3 receptors. Significant amounts of
the side-chain methylated compound and a high level of N-histamine methyltransferase
activity was seen in three cultured strains ofthe organism. This raises the possibility that
the metabolism of histamine could be altered in infected patients and the activity of the
secretagogue may be altered. The authors suggest that infection could alter the regulation
of acid secretion in opposite directions. Autoinhibition by stimulation of H3 receptors
could reduce histamine formation, but the inhibitory effect on antral somatostatin could
lead to hypergastrinemia which may enhance acid secretion. These arguments are however
speculative atpresent. Another situation in which altered histamines couldbecome important
is in inflammatory states where neutrophils abound. Hypochlorous acid generated by the
activity of myeloperoxidase present in neutrophils could lead to the formation of chlo-
ramine derivatives that could contribute to the pathophysiological effects observed [39, 40].
Thus these altered products can maintain and exaggerate the effects ofthe native molecule.
SUMMARY
Histamine released from enterochromaffln-like cells can affect diverse cellular targets
in the vicinity ofthat cell by occupying different sets ofreceptors. The responses elicited
can be terminated by diverse mechanisms. Under specific pathological states, the effects
ofhistamine can be exaggerated by the production ofnovel derivatives which may not be
significant under normal conditions.
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